As per this study the Global ADME Toxicology Testing Market was valued USD 9.7 BN (by revenue) in 2022 and is anticipated to reach USD 22.68 BN by 2030 with a CAGR of 11.2%.
ADME is an abbreviation in pharmacology that stands for absorption, distribution, metabolism, and elimination of chemicals and drugs to examine the impact in the human body. These four methods of testing define the impact of specific drug or chemical to the human tissue. ADME toxicology testing is an important procedure before an introduction of new drugs in the market. Such toxicology testing influence the drug levels and kinetics of drug exposure to the body tissue and consequently facilitated the performance in a pharmaceutical manufacturing company to lessen their drug discovery time, testing complications, and to minimize the cost of drug development.
Market Dynamics
The rising demand from different pharmaceutical and biotechnological organizations across the globe because of the decrease in the cost associated with different tests during the drug development process is stimulating market growth. Moreover, less time taking in the commercialization of new drug and decreasing number of drug testing failures are further pushing the market growth. However, high installation and maintenance cost along with the lack of skilled professionals to operate such a system is expected to curb market growth.
This detailed market study is centered on the data obtained from multiple sources and is analyzed using numerous tools including porter's five forces analysis, market attractiveness analysis and value chain analysis. These tools are employed to gain insights of the potential value of the market facilitating the business strategists with the latest growth opportunities. Additionally, these tools also provide a detailed analysis of each application/product segment in the global market of ADME toxicology testing.
Market Segmentation
The broad ADME toxicology testing market has been sub-grouped into technology, application and method. The report studies these subsets with respect to the geographical segmentation. The strategists can gain a detailed insight and devise appropriate strategies to target specific market. This detail will lead to a focused approach leading to identification of better opportunities.
By Technology
- Cell Culture
- High Throughput
- Molecular Imaging
- OMICS Technology
By Application
- Systemic Toxicity
- Renal Toxicity
- Hepatotoxicity
- Neurotoxicity
- Other Toxicities
By Method
- Cellular Assay
- Biochemical Assay
- In-Silica
- Ex-vivo
Regional Analysis
Furthermore, the report comprises of the geographical segmentation which mainly focuses on current and forecast demand for ADME toxicology testing in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The report further focuses on demand for individual application segments in all the regions.
Global ADME Toxicology Testing Market Share by Region (Representative Graph)
The report also covers detailed competitive landscape including company profiles of key players operating in the global market. The key players in the ADME Toxicology Testing market includes Thermo Fisher Scientific Inc., Promega Corp., Agilent Technologies Inc., Curia Global Inc., Dassault Systèmes, Beckman Coulter Inc., (Danaher), Catalent Inc., Charles River Laboratories, Labcorp Drug Development, Eurofins Scientific, GE HealthCare, Miltenyi Biotec, IQVIA Inc. An in-depth view of the competitive outlook includes future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other developments with information in terms of H.Q.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.